Risk factors for the development of fulminant Clostridium difficile colitis

Surgery

Volumn 143, Issue 5, 2008, Pages 623-629

  Greenstein, Alexander J ^a   Byrn, John C ^a   Zhang, Linda P ^a   Swedish, Kristin A ^a   Jahn, Alice E ^a   Divino, Celia M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANAMNESIS; ARTICLE; BACTERIAL INFECTION; CASE CONTROL STUDY; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; COLITIS; COLON RESECTION; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; FULMINANT CLOSTRIDIUM DIFFICILE COLITIS; HUMAN; INFECTION RISK; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MEDICAL DOCUMENTATION; MULTIVARIATE ANALYSIS; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURGICAL MORTALITY; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; DISEASE PROGRESSION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 43049129555     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.12.008     Document Type: Article

References (19)

1. Kelly C.P., Pothoulakis C., and LaMont J.T. Clostridium difficile colitis. N Engl J Med 330 (1994) 257-262
2. Brown E., Talbot G.H., Axelrod P., Provencher M., and Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 11 (1990) 283-290
3. Johnson S., and Gerding D.N. Clostridium difficile-associated diarrhea. Clin Infect Dis 26 (1998) 1027, 34; quiz 1035-6
4. Levy D.G., Stergachis A., McFarland L.V., Van Vorst K., Graham D.J., Johnson E.S., et al. Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting. Clin Ther 22 (2000) 91-102
5. McFarland L.V., Mulligan M.E., Kwok R.Y., and Stamm W.E. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320 (1989) 204-210
6. Kelly C.P., and LaMont J.T. Clostridium difficile infection. Annu Rev Med 49 (1998) 375-390
7. Longo W.E., Mazuski J.E., Virgo K.S., Lee P., Bahadursingh A.N., and Johnson F.E. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum 47 (2004) 1620-1626
8. Rubin M.S., Bodenstein L.E., and Kent K.C. Severe Clostridium difficile colitis. Dis Colon Rectum 38 (1995) 350-354
9. Fekety R., and Shah A.B. Diagnosis and treatment of Clostridium difficile colitis. JAMA 269 (1993) 71-75
10. Grundfest-Broniatowski S., Quader M., Alexander F., Walsh R.M., Lavery I., and Milsom J. Clostridium difficile colitis in the critically ill. Dis Colon Rectum 39 (1996) 619-623
11. Klipfel A.A., Schein M., Fahoum B., and Wise L. Acute abdomen and Clostridium difficile colitis: still a lethal combination. Dig Surg 17 (2000) 160-163
12. Synnott K., Mealy K., Merry C., Kyne L., Keane C., and Quill R. Timing of surgery for fulminating pseudomembranous colitis. Br J Surg 85 (1998) 229-231
13. Koss K., Clark M.A., Sanders D.S., Morton D., Keighley M.R., and Goh J. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis 8 (2006) 149-154
14. Dallal R.M., Harbrecht B.G., Boujoukas A.J., Sirio C.A., Farkas L.M., Lee K.K., et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 235 (2002) 363-372
15. Lamontagne F., Labbe A.C., Haeck O., Lesur O., Lalancette M., Patino C., et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 245 (2007) 267-272
16. Garcia-Osogobio S., Takahashi T., Gamboa-Dominguez A., Medina H., Arch J., Mass W., et al. Toxic pseudomembranous colitis in a patient with ulcerative colitis. Inflamm Bowel Dis 6 (2000) 188-190
17. Wang A., Takeshima F., Ikeda M., Ohnita K., Furusu H., Isomoto H., et al. Ulcerative colitis complicating pseudomembranous colitis of the right colon. J Gastroenterol 37 (2002) 309-312
18. Juang P., Skledar S.J., Zgheib N.K., Paterson D.L., Vergis E.N., Shannon W.D., et al. Clinical outcomes of intravenous immune globulin in severe Clostridium difficile-associated diarrhea. Am J Infect Control 35 (2007) 131-137
19. McPherson S., Rees C.J., Ellis R., Soo S., and Panter S.J. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Dis Colon Rectum 49 (2006) 640-645